Elevated serum levels of cysteine and tyrosine: early biomarkers in asymptomatic adults at increased risk of developing metabolic syndrome
N Mohorko, A Petelin, M Jurdana… - BioMed Research …, 2015 - Wiley Online Library
As there is effective intervention for delaying or preventing metabolic diseases, which are
often present for years before becoming clinically apparent, novel biomarkers that would …
often present for years before becoming clinically apparent, novel biomarkers that would …
Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis
M Guasch-Ferré, A Hruby, E Toledo, CB Clish… - Diabetes …, 2016 - Am Diabetes Assoc
OBJECTIVE To conduct a systematic review of cross-sectional and prospective human
studies evaluating metabolite markers identified using high-throughput metabolomics …
studies evaluating metabolite markers identified using high-throughput metabolomics …
Plasma amino acid analysis for diagnosis and amino acid-based metabolic networks
T Kimura, Y Noguchi, N Shikata… - Current Opinion in …, 2009 - journals.lww.com
Conclusion Amino acid profiling of biological samples could be used to generate indices
that could be used for clinical diagnosis and is a useful tool for understanding metabolic …
that could be used for clinical diagnosis and is a useful tool for understanding metabolic …
[HTML][HTML] Emerging perspectives on essential amino acid metabolism in obesity and the insulin-resistant state
SH Adams - Advances in nutrition, 2011 - Elsevier
Dysregulation of insulin action is most often considered in the context of impaired glucose
homeostasis, with the defining feature of diabetes mellitus being elevated blood glucose …
homeostasis, with the defining feature of diabetes mellitus being elevated blood glucose …
Obesity and diabetes related plasma amino acid alterations
Y Zhou, L Qiu, Q Xiao, Y Wang, X Meng, R Xu… - Clinical …, 2013 - Elsevier
Objectives The objective of the study is to evaluate whether plasma amino acid (AA)
differences are related with obesity or diabetes. Design and methods In 126 diabetes and …
differences are related with obesity or diabetes. Design and methods In 126 diabetes and …
[HTML][HTML] Insulin action, type 2 diabetes, and branched-chain amino acids: a two-way street
Background A strong association of obesity and insulin resistance with increased circulating
levels of branched-chain and aromatic amino acids and decreased glycine levels has been …
levels of branched-chain and aromatic amino acids and decreased glycine levels has been …
Effect of insulin sensitizer therapy on amino acids and their metabolites
Aims Prior studies have reported that elevated concentrations of several plasma amino
acids (AA), particularly branched chain (BCAA) and aromatic AA predict the onset of type 2 …
acids (AA), particularly branched chain (BCAA) and aromatic AA predict the onset of type 2 …
Plasma amino acids metabolomics' important in glucose management in type 2 diabetes
The perturbation in plasma free amino acid metabolome has been observed previously in
diabetes mellitus, and is associated with insulin resistance as well as the onset of …
diabetes mellitus, and is associated with insulin resistance as well as the onset of …
Selective amino acid deficiency in patients with impaired glucose tolerance and type 2 diabetes
BA Menge, H Schrader, PR Ritter, M Ellrichmann… - Regulatory peptides, 2010 - Elsevier
INTRODUCTION: Amino acids are important modulators of glucose metabolism, insulin
secretion and insulin sensitivity. However, little is known about the changes in amino acid …
secretion and insulin sensitivity. However, little is known about the changes in amino acid …
Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus
GA Walford, J Davis, AS Warner, RJ Ackerman… - Metabolism, 2013 - Elsevier
Objective Elevated circulating levels of branched chain and aromatic amino acids
(BCAA/AAAs) are associated with insulin resistance and incident type 2 diabetes (T2D) …
(BCAA/AAAs) are associated with insulin resistance and incident type 2 diabetes (T2D) …